Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.

Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2009 Apr;20(4):395-400. doi: 10.1111/j.1540-8167.2008.01333.x.

PMID:
19017351
2.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
3.

Practical algorithms for pharmacologic management of the post myocardial infarction patient.

Reiffel JA; American Heart Association.; American College of Cardiology..

Clin Cardiol. 2005 Nov;28(11 Suppl 1):I28-37. Review.

4.

[Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].

Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.

Ital Heart J. 2005 Nov;6 Suppl 7:14S-23S. Review. Italian.

PMID:
16485513
6.

Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.

Ellison KE, Gandhi G.

Drugs. 2005;65(6):787-97. Review.

PMID:
15819591
7.

Association between usage of beta-blocking medication and benefit from implantable cardioverter therapy.

Mäkikallio TH, Huikuri HV.

Am J Cardiol. 2006 Nov 1;98(9):1245-7. Review.

PMID:
17056339
8.

Prevention of heart failure.

Cohn JN.

Cardiology. 1999;92 Suppl 1:22-5; discussion 26-8. Review.

PMID:
10652968
9.

Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials.

Naccarella F, Naccarelli GV, Maranga SS, Lepera G, Grippo MC, Melandri F, Gatti M, Pazzaglia S, Spinelli G, Angelini V, Ambrosioni E, Borghi C, Giovagnorio MT, Nisam S.

Curr Opin Cardiol. 2002 Jan;17(1):6-18. Review.

PMID:
11790928
10.

Role of race in the pharmacotherapy of heart failure.

Kalus JS, Nappi JM.

Ann Pharmacother. 2002 Mar;36(3):471-8. Review.

PMID:
11895062
11.

Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.

Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM Jr.

J Am Coll Cardiol. 2009 Nov 24;54(22):1993-2000. doi: 10.1016/j.jacc.2009.07.039. Review.

12.

How well are chronic heart failure patients being managed?

Fonarow GC.

Rev Cardiovasc Med. 2006;7 Suppl 1:S3-11. Review.

PMID:
16955055
13.

Management of asymptomatic left ventricular dysfunction.

Haas GJ.

Cleve Clin J Med. 2001 Mar;68(3):249-55. Review.

PMID:
11263853
14.

Beta-blockers and heart failure.

Cruickshank JM.

Indian Heart J. 2010 Mar-Apr;62(2):101-10. Review.

PMID:
21180298
15.

AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.

Azadpour M, Lamas GA.

Expert Rev Cardiovasc Ther. 2004 Nov;2(6):891-902. Review.

PMID:
15500434
16.
17.

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E; BEST Investigators..

J Card Fail. 2003 Oct;9(5):354-63. Review.

PMID:
14583895
18.

Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials.

Gheorghiade M, Benatar D, Konstam MA, Stoukides CA, Bonow RO.

Am J Cardiol. 1997 Oct 30;80(8B):14H-27H. Review. Erratum in: Am J Cardiol 1998 Jun 15;81(12):1521.

PMID:
9372994
19.

Clinical trials of beta-blockers in heart failure: a class review.

Yancy CW.

Am J Med. 2001 Apr 2;110 Suppl 5A:7S-10S. Review.

PMID:
11259751
20.

Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.

Fonarow GC, Gheorghiade M, Abraham WT.

Am J Cardiol. 2004 Nov 1;94(9):1155-60. Review.

PMID:
15518610
Items per page

Supplemental Content

Support Center